These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 89622)

  • 21. [Role of immunologic factors in the pathogenesis of chronic active liver diseases].
    Bergiel A
    Przegl Epidemiol; 1974; 28(2):131-7. PubMed ID: 4849657
    [No Abstract]   [Full Text] [Related]  

  • 22. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
    Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic aspects of liver disease.
    Kanagasundaram N; Leevy CM
    Med Clin North Am; 1979 May; 63(3):631-42. PubMed ID: 376975
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions.
    Hosoda H; Okawa-Takatsuji M; Tanaka A; Uwatoko S; Aotsuka S; Hasimoto N; Ozaki Y; Ikeda Y
    Clin Chim Acta; 2004 Apr; 342(1-2):71-81. PubMed ID: 15026266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated cytotoxicity in chronic active liver disease: a new test system.
    Vogten AJ; Hadzic N; Shorter RG; Summerskill WH; Taylor WF
    Gastroenterology; 1978 May; 74(5 Pt 1):883-9. PubMed ID: 565311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.
    Fernandez-Cruz E; Escartin P; Bootello A; Kreisler M; Segovia de Arana JM
    Clin Exp Immunol; 1978 Mar; 31(3):436-42. PubMed ID: 657588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunology of liver diseases].
    Meyer zum Büschenfelde KH
    Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-1-Foeto protein (AFP) and hepatitis B surface antigen (HBsAg) in various hepatic disorders.
    Gupta SC; Satsangi JK; Mehrotra TN; Sinha SN
    J Assoc Physicians India; 1979 Jan; 27(1):1-6. PubMed ID: 92470
    [No Abstract]   [Full Text] [Related]  

  • 29. [Demonstration of a serum and liver antigen in acute or chronic non A-non B viral hepatitis].
    Trepo C; Vitvitski L; Pichoud C; Perche G; Beorchia S; Sepetjan M; Brette R
    Nouv Presse Med; 1979 Nov; 8(43):3539-42. PubMed ID: 120941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.
    Lohse AW; Gerken G; Mohr H; Löhr HF; Treichel U; Dienes HP; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1995 Sep; 33(9):527-33. PubMed ID: 8525656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis.
    Paronetto F; Schaffner F; Popper H
    J Lab Clin Med; 1967 Jun; 69(6):979-88. PubMed ID: 4960941
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hepatitis B virus DNA in hepatitis B surface antigen-negative patients with chronic liver disease].
    Jilg W
    Dtsch Med Wochenschr; 1985 Jun; 110(25):1017-8. PubMed ID: 2408841
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology of liver disease.
    Triger DR
    Acta Med Port; 1981; (Suppl 2):21-33. PubMed ID: 6453499
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial, viral and auto antibodies in acute and chronic liver disease.
    Triger DR
    Ann Clin Res; 1976 Jun; 8(3):174-81. PubMed ID: 793498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current status of the theories of the chronicity of liver diseases].
    Damianov B
    Vutr Boles; 1981; 20(2):25-32. PubMed ID: 7020250
    [No Abstract]   [Full Text] [Related]  

  • 39. Liver membrane autoantibodies: methods for their detection and clinical significance.
    Nagai S; Manns M; Meyer zum Büschenfelde KH
    Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to ribosomes in chronic active hepatitis.
    Gerber MA; Shapiro JM; Smith H; Lebwohl O; Schaffner F
    Gastroenterology; 1979 Jan; 76(1):139-43. PubMed ID: 758135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.